[A novel antiepileptic, gabapentin (GABAPEN)]

MeSH terms

• Amines* / adverse effects
• Amines* / pharmacokinetics
• Amines* / pharmacology
• Amines* / therapeutic use
• Animals
• Anticonvulsants* / adverse effects
• Anticonvulsants* / pharmacokinetics
• Anticonvulsants* / pharmacology
• Anticonvulsants* / therapeutic use
• Brain / metabolism
• Calcium Channels / metabolism
• Clinical Trials, Phase III as Topic
• Cyclohexanecarboxylic Acids* / adverse effects
• Cyclohexanecarboxylic Acids* / pharmacokinetics
• Cyclohexanecarboxylic Acids* / pharmacology
• Cyclohexanecarboxylic Acids* / therapeutic use
• Drug Interactions
• Drug Therapy, Combination
• Epilepsies, Partial / drug therapy*
• GABA Plasma Membrane Transport Proteins / metabolism
• Gabapentin
• Humans
• Protein Binding
• gamma-Aminobutyric Acid* / adverse effects
• gamma-Aminobutyric Acid* / metabolism
• gamma-Aminobutyric Acid* / pharmacokinetics
• gamma-Aminobutyric Acid* / pharmacology
• gamma-Aminobutyric Acid* / therapeutic use